Formatted resume available upon request

SUMMARY:
I have 15+ years experience as a synthetic organic/medicinal chemist in both aca
demia and the pharmaceutical industry. I am an accomplished scientific and chem
istry team leader utilizing independent scientific thought to formulate medicina
l hypotheses and design compounds to test them. I have provided key contributio
ns to global strategic initiatives implemented to strengthen infrastructure and
improve processes. Examples include: a strategy for compound acquisition and ca
pital equipment purchase ($500K); chemistry business unit leader for a lab suppl
y and reagent management team delivering a global solution resulting in ~$70K/mo
nth savings and increased safety compliance. I have experience leading risk sha
ring projects executing research plans in collaboration with external partners.
My management experience includes scientific goal and strategy setting, executio
n, and laboratory supervision.
PROFESSIONAL EXPERIENCE:
2003-present Eli Lilly & Company, Indianapolis, IN, Research Advisor, Discovery
Chemistry Research and Technologies (2006-present); Principle Research Scientis
t, (2003-2006)
Lead chemist and project team leader on multidisciplinary efforts in diverse the
rapeutic areas including cancer, inflammation and pain. Teams included specialis
ts in chemistry, biology, drug disposition, and toxicology
Lead chemist and project leader on 5 discovery efforts developing inhibitors of
cell surface G-protein coupled receptors (GPCR) for targeted and selective drugs
in oncology. Experience moving from target validation to lead development
Leadership on multinational projects with external partner collaborators and uti
lization of contract research chemistry resources (CRO)
7 Lean Six Sigma projects: Co-sponsor for a global reference standard request pr
ocess and contributor to transformational processes in early lead generation
Structure based drug design effort for the protease DPP-IV for diabetes. 3 paten
t applications
Direct supervision and development of 1-2 MS level chemist with performance mana
gement and supervision of 3 external contract research (CRO) chemists
Coached and mentored junior and senior cross-functional scientists

2000-2003 Pharmacia, Kalamazoo, MI, Senior Research Scientist, Medicinal Chemist

ry
Experience in CNS (Alzheimers) pharmacology
Structure based drug design for the aspartyl protease BACE
Manager of 9 external contract research chemists to support project team
Co-inventor on 8 issued patents on compounds for Alzheimers
Supervisor of 1-2 MS level chemists
1995-2000 University of Missouri, Columbia, MO, Assistant Professor of Organic C
hemistry
Research grants totaling > $700,000 including NIH R01GM59350-01
Advisor for 16 undergraduate, graduate, and post-graduate students
Teaching responsibility for undergraduate and graduate chemistry courses
1993-1995 Stanford University, Palo Alto, CA, American Cancer Society Postdoctor
al Fellow: Advisor: Dr. Barry M. Trost
Asymmetric palladium catalysis; Natural product synthesis- (+)-Pancratistatin
EDUCATION:
1993 Ph.D., Synthetic Organic Chemistry, Colorado State University, Ft. Collins,
CO
1988 B.S., Cum Laude, Chemistry, Utah State University, Logan, UT
PROFESSIONAL ORGANIZATIONS:
American Chemical Society
Phi Kappa Phi
LinkedIn groups: Drug Discovery and Development, Biotech & Pharma Professionals
Network, GPCR and Ion Channel Drug Discovery, Medicinal Chemistry and Drug Disco
very, and Oncology
AWARDS:
Lilly Research Laboratories Presidents Award: For outstanding scientific achieve
ments contributing to the success of the global LRL community- 2005
RECENT PATENTS AND PUBLICATIONS: complete list available upon request
Compounds to treat Alzheimers disease, US Patent 7,214,715
Marocycles useful in the treatment of Alzheimers disease, US Patent 7,067,507
Rapid and Recurrent Neutrophil Mobilization Regulated by T134, A CXCR4 Peptide A
ntagonist. Experimental Hematology 2008, 36(9), 1098-1109.
CCR5 Antagonists: From Discovery to Clinical Efficacy in Chemokine Biology-Basic
Research and Clinical Application 2007, 2, 145-163.
Discovery of Non-Covalent Dipeptidyl Peptidase IV Inhibitors Which Induce a Conf
ormational Change in the Active Site. Bioorg. Med. Chem. Lett. 2007, 17(6) 1765
-1768.
REFERENCES: available upon request
KEYWORDS: Titles: research chemist, medicinal chemist, Sr. scientist, senior sci
entist, principle scientist, scientist (chemistry), advisor, group leader, manag
er, supervisor, organic chemist, synthetic chemist, Ph.D. chemist, literature se
arching, drug discovery, drug development, patent, intellectual property, pharma
ceuticals, small-molecule synthesis, synthetic organic, laboratory management, d
eveloping, mentoring, medical liaison, patent agent, management consulting, regu
latory affairs, animal health and agricultural sciences, business development